2m 2m 2m 2m 2m 2m 2m
Tenet Healthcare (THC)
NYSE
$180.68+$1.93 (+1.08%)
Price as of Jun 23, 2026 3:56 PM EDT- $15.4BMarket Cap
- 5.69%1-Year Change
- Medical Care FacilitiesIndustry
Tenet Healthcare (THC)
$180.68+$1.93 (+1.08%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 21.3B +3.12% | 20.7B +0.57% | 20.5B +7.17% | 19.2B -1.60% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 21.3B +3.12% | 20.7B +0.57% | 20.5B +7.17% | 19.2B -1.60% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 863.0M +5.50% | 818.0M -5.98% | 870.0M +3.45% | 841.0M -1.64% | |
Total Operating Expenses | 4.5B +0.69% | 4.5B -0.51% | 4.5B +12.93% | 4.0B -4.95% | |
Operating Profit | 3.5B -41.10% | 6.0B +137.29% | 2.5B +7.59% | 2.3B -18.74% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -901.0M +1.24% | -890.0M -3.58% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -901.0M +1.24% | -890.0M -3.58% | |
Total Nonoperating Income and Expense | 117.0M -7.14% | 126.0M +563.16% | 19.0M +90.00% | 10.0M -28.57% | |
Income before Taxes | 2.8B -46.65% | 5.2B +224.55% | 1.6B +20.31% | 1.3B -28.81% | |
Income Taxes | 433.0M -63.43% | 1.2B +286.93% | 306.0M -11.05% | 344.0M -16.30% | |
Extraordinary Items | 61.0M +771.43% | 7.0M -83.72% | 43.0M -54.26% | 94.0M +1,075.00% | |
Net Income | 2.4B -41.76% | 4.1B +209.99% | 1.3B +30.97% | 1.0B -32.18% | |
Net Income from Continuing Operations Applicable to Common | 1.4B -56.03% | 3.2B +423.73% | 611.0M +49.02% | 410.0M -55.19% | |
Basic EPS and Net Income | 15.61 -52.73% | 33.02 +449.42% | 6.01 +56.51% | 3.84 -55.09% | |
Diluted EPS and Net Income | 15.49 -52.63% | 32.70 +472.68% | 5.71 +50.66% | 3.79 -54.99% | |
Basic Weighted Average Shares | 90.2M -6.97% | 96.9M -4.66% | 101.6M -4.95% | 106.9M +0.09% | |
Diluted Weighted Average Shares | 90.8M -7.20% | 97.9M -6.60% | 104.8M -5.17% | 110.5M +1.79% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.9B -4.50% | 3.0B +145.85% | 1.2B +43.12% | 858.0M -63.71% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.9B -4.50% | 3.0B +145.85% | 1.2B +43.12% | 858.0M -63.71% | |
Total Current Assets | 7.8B +2.17% | 7.7B +7.19% | 7.2B +19.83% | 6.0B -15.46% | |
Accumulated Depreciation | 6.7B +14.99% | 5.8B -10.33% | 6.5B +4.47% | 6.2B +4.04% | |
Property and Plant and Equipment and Net | 6.3B +4.40% | 6.0B -3.00% | 6.2B -3.50% | 6.5B +0.54% | |
Total Long-Term Assets | 1.3B -0.81% | 1.4B +0.22% | 1.4B -0.07% | 1.4B -2.45% | |
Total Assets | 29.7B +2.56% | 28.9B +2.20% | 28.3B +4.26% | 27.2B -1.53% | |
Income Taxes Payable | 240.0M -2.04% | 245.0M -24.85% | 326.0M +50.23% | 217.0M +502.78% | |
Total Short-Term Debt | 79.0M -14.13% | 92.0M -23.33% | 120.0M -17.24% | 145.0M +7.41% | |
Total Current Liabilities | 4.5B +3.55% | 4.3B -9.45% | 4.8B +6.34% | 4.5B -12.39% | |
Total Long-Term Debt | 13.1B +0.08% | 13.1B -12.10% | 14.9B -0.35% | 14.9B -3.72% | |
Total Long-Term Liabilities | 1.7B +8.90% | 1.6B -7.96% | 1.7B -4.36% | 1.8B +24.18% | |
Total Liabilities | 20.7B +1.54% | 20.4B -10.59% | 22.8B +1.14% | 22.5B -3.32% | |
Retained Earnings | 4.4B +46.78% | 3.0B +1,666.67% | -192.0M -76.09% | -803.0M -33.86% | |
Total Stockholders Equity | 4.2B +1.17% | 4.2B +159.39% | 1.6B +40.81% | 1.1B +11.09% | |
Total Shares Outstanding | 158.6M +0.39% | 158.0M +0.46% | 157.3M +0.52% | 156.5M +0.61% | |
Cash Flow | |||||
Cash from Operating Activities | 3.5B +72.94% | 2.0B -13.77% | 2.4B +119.21% | 1.1B -30.93% | |
Capital Expenditures | 1.0B +8.49% | 931.0M +23.97% | 751.0M -1.44% | 762.0M +15.81% | |
Cash from Investing Activities | -1.3B -137.18% | 3.4B +453.87% | -969.0M +19.93% | -808.0M +13.17% | |
Dividends Paid | 809.0M +18.80% | 681.0M +14.65% | 594.0M +6.07% | 560.0M +32.39% | |
Cash from Financing Activities | -2.4B -34.84% | -3.7B +256.04% | -1.0B -41.89% | -1.8B +90.28% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 16.46% -42.88% | 28.82% +135.95% | 12.22% +0.39% | 12.17% -17.42% | |
Return on Assets | 8.08% -43.11% | 14.20% +200.36% | 4.73% +29.24% | 3.66% -32.24% | |
Return on Equity | 56.42% -59.89% | 140.65% +47.51% | 95.35% +3.35% | 92.26% -67.00% | |
Revenue Growth | 3.12% +448.16% | 0.57% -92.05% | 7.17% +548.97% | -1.60% -115.26% | |
Current Ratio | 1.76 -1.33% | 1.78 +18.38% | 1.51 +12.69% | 1.34 -3.51% | |
Cash Ratio | 0.65 -7.78% | 0.70 +171.51% | 0.26 +34.59% | 0.19 -58.57% | |
Debt-to-Equity Ratio | 3.12 -1.17% | 3.16 -66.15% | 9.33 -29.34% | 13.20 -13.24% | |
Debt-to-Assets Ratio | 0.44 -2.50% | 0.46 -14.10% | 0.53 -4.57% | 0.56 -2.12% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow